Toward better models of hyperthyroid Graves' disease

Selçuk Dağdelen1, Yi-chi M Kong, J Paul Banga

  • 1Department of Diabetes and Endocrinology, King's College London School of Medicine, Denmark Hill Campus, The Rayne Institute, London, UK. selcuk.dagdelen@kcl.ac.uk

Insights

Developing better animal models for Graves' disease is crucial for understanding hyperthyroidism and its associated ophthalmopathy. This research clarifies the immunology and potential therapeutic strategies for this human-specific autoimmune disorder.

Area of Science:

  • Endocrinology
  • Immunology
  • Translational Medicine

Background:

  • Graves' disease is a human-specific autoimmune disorder causing hyperthyroidism.
  • Current antithyroid drug treatments have high recurrence rates and imperfect outcomes.
  • The etiology and treatment of Graves' ophthalmopathy remain significant challenges.

Purpose of the Study:

  • To discuss the development of improved experimental models for hyperthyroid Graves' disease.
  • To explore how animal models can advance the understanding of Graves' disease pathogenesis.
  • To highlight the contribution of this research to clarifying the disease's immunology.

Main Methods:

  • Review and discussion of the ongoing pursuit of suitable animal models.
  • Analysis of how experimental models have elucidated the immunological aspects of Graves' disease.
  • Evaluation of the potential of animal models for testing novel therapeutic strategies.

Main Results:

  • The development of experimental models has been essential for studying Graves' disease.
  • Research using these models has significantly clarified the underlying immunology of the condition.
  • Animal models offer a platform for investigating pathogenesis and evaluating new treatments.

Conclusions:

  • Improved animal models are vital for advancing research into Graves' disease.
  • Understanding the immunology through these models can lead to better therapeutic strategies.
  • Further development of experimental models is key to overcoming treatment limitations in Graves' disease and its ophthalmopathy.

Related Concept Videos

Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...